Dr. Tim Schwarz

Tim is a member of the Technology, Media & Telecommunications practice and specializes in technology transactions and data protection law. Tim focuses in particular on transactions driven by the use, licensing and exploitation of digital technologies and intellectual property rights.

In this context, he advises clients in particular on the structuring and negotiation of a variety of complex technology transactions, including acquisition and distribution, licensing, outsourcing and research & development. Another focus of Tim’s practice lies in the area of data protection law, where he advises on all aspects that may arise in the context of data security and privacy, with a strong focus on the healthcare, life science as well as the financial services industries. Tim's clients include national and international technology, healthcare, financial services and Fintech companies at all stages of growth, from promising start-ups to industry-leading multinational public companies.

Coffee Break Life Sciences Start-ups | Our new webinar series

Every third Wednesday of the month in 2025.

CV

Since 2021 Salary Partner, Taylor Wessing

2017 – 2021 Senior Associate, Taylor Wessing

2015 – 2016 Baker McKenzie

职业发展

Since 2021 Salary Partner, Taylor Wessing

2017 – 2021 Senior Associate, Taylor Wessing

2015 – 2016 Baker McKenzie

教育

2015 Admitted as a lawyer, Munich

2015 Doctoral degree on copyright licenses, Albert–Ludwigs–Universität Freiburg

2014 Second state examination, Berlin

会员资格和附属关系

Deutsche Gesellschaft für Recht und Informatik (German Association of Law and Informatics)

语言

奖励

Legal 500 Germany 2024

Featured

German Institute for Legal Departments and Corporate Lawyers (diruj) 2020/2021/2022

最新新闻和观点

View Tim 's insights

点击此处了解更多

公司/并购与资本市场

Taylor Wessing advises Union Park Capital on the acquisition of autoVimation GmbH

2025年4月3日

作者

Synapse - AI in Life Sciences

Purpose limitation and data minimisation: key considerations for AI training in the life sciences sector

The use of real-world evidence data to train AI models is becoming a critical component in advancing research and drug development. We explore how two of the GDPR's guiding principles are more than just regulatory requirements.

2025年3月6日

作者 Victoria Hordern 以及 Dr. Tim Schwarz

3 / 10 观点

点击此处了解更多

公司/并购与资本市场

Taylor Wessing advises insolvency administrator on the sale of the ZIEGLER-wood processing division to Rettenmeier

2025年1月31日

作者

点击此处了解更多

Dr. Tim Schwarz

Legal 500 Germany 2024

专长

执业领域和服务团队

CV

职业发展

教育

会员资格和附属关系

语言

奖励

Legal 500 Germany 2024

German Institute for Legal Departments and Corporate Lawyers (diruj) 2020/2021/2022

最新新闻和观点

Taylor Wessing advises Union Park Capital on the acquisition of autoVimation GmbH

与我会面：

5月22日

13:00 - 13:45

Implementing the EU Data Act: Digital Medical Devices and Health Apps in Focus

Dr. Tim Schwarz

Legal 500 Germany 2024

专长

执业领域和服务团队

CV

职业发展

教育

会员资格和附属关系

语言

奖励

Legal 500 Germany 2024

German Institute for Legal Departments and Corporate Lawyers (diruj) 2020/2021/2022

最新新闻和观点

Taylor Wessing advises Union Park Capital on the acquisition of autoVimation GmbH

Related news & insights

Advising Day Wireless on the acquisition of Sigma Wireless Communications

New US Rules on Data Transfers: What companies need to know about the "Bulk Data Rule"

From the US to UK: strategies for securing reputation and privacy

UK Cyber Security and Resilience Bill – government provides details

Advocate General: Even Free Offers Can Constitute a “Sale” Under the ePrivacy Directive – No Need to Rely on Article 6 GDPR

GDPR Disputes: AG Ćapeta Backs Direct Actions vs EDPB Decisions (WhatsApp)

Online Safety Act illegal harms Codes of Practice now enforceable

Clarity on application of DMCCA consumer protection regime

German Federal Court of Justice (BGH): Consumer protection associations have the right to sue if GDPR information obligations are violated

Freedom of expression and the right to reputation: finding the right balance

相关人员

与我会面：

5月22日

13:00 - 13:45

Implementing the EU Data Act: Digital Medical Devices and Health Apps in Focus